NCT00709189View on ClinicalTrials.gov

Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

August 31, 2005

Conditions
Female ContraceptionContraceptionTherapeutic EquivalencyPharmacokinetics
Interventions
DRUG

Norgestimate/Ehinyl Estradiol; Folic acid.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00709189 - Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. | Biotech Hunter | Biotech Hunter